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a b s t r a c t
Human herpesvirus-6 (HHV-6) and -7 (HHV-7) are Roseoloviruses within the Betaherpesvirus family,
which have a high prevalence and suspected involvement in a number of diseases. Using CODEHOP-
based PCR, we identiﬁed homologs of both viruses in saliva of pig-tailed macaques, provisionally named
MneHV-6 and MneHV-7. This ﬁnding supports the existence of two distinct Roseolovirus lineages before
the divergence of humans and macaques. Using speciﬁc qPCR assays, high levels of MneHV-6 and
MneHV-7 DNA were detected in macaque saliva, although the frequency was greater for MneHV-7. A
blood screen of 283 macaques revealed 10% MneHV-6 DNA positivity and 25% MneHV-7 positivity, with
higher prevalences of MneHV-6 in older females and of MneHV-7 in younger males. Levels of MneHV-6
were increased in animals coinfected with MneHV-7, and both viruses were frequently detected in
salivary gland and stomach tissues. Our discovery provides a unique animal model to answer unresolved
questions regarding Roseolovirus pathology.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
Herpesviruses comprise a family of relatively large double-
stranded DNA viruses, which are widespread among humans and
other animals. Both the Cytomegalovirus and the Roseolovirus
genera in the Betaherpesvirinae subfamily include viruses found
in humans. The Roseolovirus genus is composed of three human
viruses: the closely related human herpesvirus 6A (HHV-6A) and
human herpesvirus 6B (HHV-6B) and the more distantly related
human herpesvirus 7 (HHV-7) (Pringle, 1998). Although HHV-6A
and HHV-6B were originally considered as two variants of the
same virus ( Ablashi, 1993), evidence of genetic, biological and
epidemiologic differences between HHV-6A and HHV-6B has led
to their recent classiﬁcation as distinct virus species (Adams and
Carstens, 2012).
Roseoloviruses are among the most prevalent viruses in the
human population with primary infection occurring during early
childhood (Hall et al., 2006; Zerr et al., 2005). Primary infections
with HHV-6B and HHV-7 have been reported to cause exanthema
subitum (Tanaka et al., 1994; Yamanishi et al., 1988) while the
clinical symptoms associated with HHV-6A are still unclear. These
clinical features associated with roseolovirus infections are gen-
erally characterized by low morbidity, as the virus infection
becomes latent. However, severe pathological conditions can arise
due to active viral replication, often in immunocompromised
hosts. In transplant patients HHV-6B reactivation is associated
with frequent complications including encephalitis, acute graft
versus host disease, CMV reactivation and bone marrow suppres-
sion (Zerr, 2012). In this setting, the causal involvement of HHV-7
reactivation is less well documented. HHV-6B is also implicated in
a majority of pediatric cases of febrile status epilepticus (Epstein
et al., 2012). HHV-6A active replication on the other hand is
associated with autoimmune diseases such as Hasimoto's thyroi-
ditis (Caselli et al., 2012) and enhances disease progression in HIV
infected individuals (Ablashi et al., 1998; Boutolleau et al., 2004;
Lusso et al., 2007).
Both HHV-6B and HHV-7 are believed to be transmitted by ex-
posure to saliva. Infectious virus particles can be isolated from saliva
samples and both viruses have been detected in salivary glands (Di
Luca et al., 1995). In contrast HHV-6A is rarely detected in saliva
(Aberle et al., 1996) and it is likely that transmission occurs following
other types of exposure including sexual contact (Leach et al., 1994).
To date, no signiﬁcant differences in prevalence of roseolovirus
infections in men and women have been reported. However, large
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variations in prevalence have been observed in different geographic
locations (Krueger et al., 1998; Magalhaes et al., 2010).
All roseoloviruses were initially characterized by their tropism
for lymphocytes (Frenkel et al., 1990; Salahuddin et al., 1986).
However, since these viruses can infect and replicate in a wide
range of tissues, a broader cellular tropism is likely. Although
HHV-6 and HHV-7 have been detected in a similar panel of tissues
(Chen and Hudnall, 2006; Kempf et al., 1998; Mori, 2009), it is
likely that they infect different cell types since each virus relies on
a different membrane receptor for viral entry (Lusso et al., 1994b;
Santoro et al., 1999; Tang et al., 2013).
To our knowledge, no roseolovirus homolog has been identiﬁed in
any of the three major macaque species used in research, including
long-tailed macaques (Macaca fascicularis (Mfa)), Rhesus macaques
(Macaca mulata (Mmu)), and pig-tailed macaques (Macaca nemestrina
(Mne)). The only non-human primate roseloviruses discovered to date
are a HHV-6 homolog in chimpanzee (PanHV6) (Lacoste et al., 2005)
and a roseolovirus in drill monkeys (MndHVbeta) (Lacoste et al.,
2000). Both viral homologs were identiﬁed in DNA isolated from blood
by nested PCR using the consensus-degenerate hybrid oligonucleotide
primer (CODEHOP) approach. Nonetheless, HHV-6 reactive antibodies
have been detected in a number of primate species, including
macaque species, orangutans and African green monkeys, suggesting
the existence of additional roseolovirus homologs (Higashi et al., 1989).
In the current study, we investigated whether pig-tailed maca-
ques maintained at the Washington National Primate Research
Center (WaNPRC) were naturally infected with Roseolovirus homo-
logs using a CODEHOP PCR approach speciﬁcally designed to detect
novel roseoloviruses. We identiﬁed multiple DNA fragments in pig-
tailed macaques with strong sequence homology to HHV-6A,
HHV-6B, and HHV-7. Phylogenetic analysis revealed that these
DNA fragments corresponded to two novel Roseoloviruses belonging
to the beta-herpesvirus subfamily. One viral sequence clustered
closely with HHV-6A and -6B and panHV-6 suggesting that it was
derived from the pig-tailed macaque homolog of HHV-6, provision-
ally termed MneHV-6. The other viral sequence clustered closely
with HHV-7, suggesting that it was derived from the pig-tailed
macaque homolog of HHV-7, provisionally termed MneHV-7. Using
speciﬁc quantitative TaqMan PCR assays, we determined that the
prevalence and tissue tropism of MneHV-6 and MneHV-7 were
similar to HHV-6 and HHV-7 in humans. Our studies suggest that
pig-tailed macaques naturally infected with MneHV-6 and MneHV-7
can be used as biologically relevant animal models to study HHV-6
and HHV-7 infections and associated pathologies in the human host.
Results
Development of CODEHOP PCR assays to identify novel roseoloviruses
In order to identify novel members of the Roseolovirus genus
among the Betaherpesvirinae subfamily in Old World monkey
species, we used the Consensus-Degenerate Hybrid Oligonucleotide
Primer (CODEHOP) technique (Rose et al., 1998) to develop PCR
primers targeting the highly conserved DNA polymerase (DNA pol)
and glycoprotein B (gB) genes, as done previously (Rose, 2005).
Amino acid motifs conserved within the known member species of
the Betaherpesvirinae subfamily were used to design CODEHOP
primer pairs that would preferentially amplify members of the
betaherpesvirus family. Several primer pairs were designed using
the iCODEHOP software (Boyce et al., 2009) targeting multiple
conserved sites within the DNA pol and the gB genes. CODEHOP
primers with low degeneracy and with a sequence bias for the
known roseolovirus sequences were selected. Inosine was intro-
duced into the degenerate cores of some primers to further lower
degeneracy, and some primer consensus sequences were adjusted to
more speciﬁcally target roseolovirus sequences. Primers were then
paired based on compatible annealing temperatures and suitable
amplicon lengths. Forty-six DNA pol-speciﬁc and 16 gB-speciﬁc
CODEHOP primer pairs targeting different regions of the DNA pol
and gB genes were tested with DNA from the HBS-2 cell line infected
with the HHV-6A strain U1102 (Downing et al., 1987). Since the
optimal annealing temperature of each CODEHOP primer pool to a
novel template is not known, initial PCR reactions were performed
using a temperature gradient from 50 1C to 70 1C. PCR products were
then resolved on agarose gels (data not shown). Five DNA pol-
speciﬁc and ﬁfteen gB-speciﬁc CODEHOP primer pairs displayed
robust ampliﬁcation of HHV-6A over the entire temperature gradi-
ent and showed minimal non-speciﬁc ampliﬁcation.
Identiﬁcation of a pig-tailed macaque homolog of HHV-6
Since HHV-6 is often detected in human saliva, whole saliva
from macaques was used as a source of DNA to screen for the
presence of a macaque roseolovirus homolog. Archived saliva
samples were available from ﬁve pig-tailed macaques that had
been challenged with SHIV in a previous vaccine study at the
WaNPRC (Polacino et al., 2008). Two of the animals (M03126 and
M03182) had detectable viral loads of SHIV in their plasma and
three animals (M02383, M02156 and L02393) were negative. DNA
isolated from the ﬁve saliva samples was tested by PCR using the
CODEHOP primers SLYP-F (forward) and YGD-R (reverse). These
primers, which target the highly conserved “SLYP” and “YGD”
amino acid motifs within the DNA pol gene (Fig. 1), had given a
strong ampliﬁcation signal with DNA from the HHV-6A infected
HSB-2 cell line. This primer pair is similar to CODEHOP primers we
have used previously to identify unknown macaque gamma-
herpesviruses (Rose, 2005), but is biased towards roseoloviruses.
Using the SLYP-F / YGD-R primer pair with an annealing tempera-
ture of 60 1C, we detected a PCR amplicon of the expected size
(550bp) in one of the ﬁve macaques tested (Table 1). Following
gel puriﬁcation and Sanger sequencing, we obtained a 478bp
nucleotide sequence of the ampliﬁed DNA fragment between the
ﬂanking primer sequences. We compared the nucleotide sequence
to the non-redundant GenBank nucleotide database (NCBI) using
BLASTN. The closest matches were partial DNA pol nucleotide
sequences from different herpes 6 viruses (Pan troglodytes her-
pesvirus 6 (PanHV6), HHV-6B (strain Z29) and HHV-6A (strain
U1102)) with at least 75% identity (Table 2). This suggested that we
had identiﬁed a novel roseolovirus DNA pol sequence correspond-
ing to a pig-tailed macaque homolog of HHV-6, provisionally
named MneHV-6.
To obtain additional sequence for MneHV-6, additional CODEHOP
primer pairs were used to amplify DNA from the same previously
positive animal (M02156). The DNA pol-speciﬁc CODEHOP primer
pair DIEC-F/CNS-R produced an amplicon at 60 1C, which contained a
sequence that overlapped the previous MneHV-6 DNA fragment,
generating a 1313bp long contiguous sequence of the MneHV-6
DNA pol gene (Fig. 1). Alignment of this sequence with other
roseolovirus DNA pol sequences revealed highest nucleotide identity
with known human and chimpanzee herpesviruses 6 (Table 2). We
also used a CODEHOP primer pair (NPFG/PLEN) targeting motifs
conserved in the roseolovirus gB sequences. The NPFG/PLEN assay
produced 326bp PCR amplicons at both 50 1C and 60 1C annealing
temperatures from the saliva of only one animal (M02156). No PCR
products were detected in the other macaque samples. Both ampli-
cons were gel-puriﬁed and sequenced revealing the same 262bp
sequence ﬂanked by the primers (Fig. 1, Table 1). Nucleotide sequence
comparisons with known roseolovirus gB sequences showed again
the highest identity with HHV-6B, HHV-6A, and with the chimpanzee
PanHV6 gB sequences. Sequence analysis from two independently
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isolated gene fragments conﬁrmed our identiﬁcation of a novel
pigtailed macaque homolog of HHV-6.
Identiﬁcation of a pig-tailed macaque homolog of HHV-7
To continue the search for other roseolovirus homologs, we
tested the same 5 saliva samples using the DNA pol-speciﬁc
CODEHOP primers (SLYP-F, YGD-R) at a lower annealing tempera-
ture (50 1C). Low annealing temperatures allow primers to bind to
a broader range of mismatched templates, enhancing the possibi-
lity of capturing more distantly related sequences. Using this
annealing temperature, we detected PCR amplicons of the
expected sizes (550bp) in all ﬁve of the macaque saliva samples.
All PCR products were gel-puriﬁed and the ampliﬁed DNA frag-
ments were sequenced, yielding the same 478bp sequence. A
comparison of this sequence with the MneHV-6 DNA pol sequence
mentioned above showed only 62% nucleotide identity. BLASTN
search of the NCBI database revealed a closer match with the DNA
pol sequence of HHV-7 (Table 2). Alignment with other roseolo-
virus DNA pol sequences showed lower nucleotide identities. We
were unable to obtain additional overlapping sequences using the
remaining DNA pol CODEHOP primers, nor did we detect another
PCR amplicon with the gB CODEHOP primers at either annealing
temperature. The close similarity of the 478bp DNA pol sequence
with HHV-7 suggests that we have identiﬁed a novel pig-tailed
macaque homolog of HHV-7, provisionally termed MneHV-7. This
virus appeared to be more widely distributed than MneHV-6, since
all 5 animals were positive in our initial PCR screen (Table 1).
Phylogenetic relationship of MneHV-6 and MneHV-7
To establish the phylogenetic relationship between the putative
macaque roseoloviruses and known herpesviruses, we aligned the
protein sequences encoded by the 478bp DNA fragments of the
putative MneHV-6 and MneHV-7 DNA pol genes with the corre-
sponding sequences from other herpesviruses, using the MUSCLE
software and determined the phylogenetic relationship based on
the Maximum Likelihood algorithm (PhyML). The MneHV-6 DNA
pol sequence clustered with the DNA pol sequences of HHV-6A,
HHV-6B and chimpanzee PanHV6 within the beta-herpesvirus
subfamily (Fig. 2). This clustering supported the identity of
MneHV-6 as a HHV-6 homolog in the pig-tailed macaque. Con-
versely, the MneHV-7 DNA pol sequence clustered with the DNA
pol sequences of HHV-7 supporting the identity of MneHV-7 as a.
HHV-7 homolog in the pig-tailed macaque.
To investigate more closely the relationship between the
primate roseolovirus sequences, we performed a maximum like-
lihood analysis of the nucleotide sequences of the CODEHOP DNA
pol fragments of MneHV-6 and MneHV-7 and the corresponding
sequences from known roseoloviruses. As seen with the amino
acid analysis, the MneHV-6 DNA pol nucleotide sequence clustered
with the HHV-6A, HHV-6B and PanHV6 sequences conﬁrming the
close association between these HHV-6 homologs (Fig. 3). The
clustering relationship of the MneHV-6, PanHV6 and the two
human HHV-6 species is consistent with a long term co-
evolution of these HHV-6 homologs with their primate host
species and further supports the identity of MneHV-6 as a
macaque homolog of HHV-6. The MneHV-7 DNA pol nucleotide
sequence clustered with the HHV-7 sequence, further conﬁrming
its identity as a macaque homolog of HHV-7 (Fig. 3).
Development of MneHV-6 and MneHV-7 speciﬁc quantitative
PCR assays
To conduct more sensitive and comprehensive screening of pig-
tailed macaques for roseolovirus infection and to determine viral
loads in various tissues, we developed speciﬁc quantitative real-
time PCR assays (qPCR) based on primers and TaqMan probes
targeting the MneHV-7 DNA pol or the MneHV-6 gB gene segment
identiﬁed with our CODEHOP assays (Fig. 1). For assay optimiza-
tion and accurate quantiﬁcation of assay efﬁciencies, we created
Table 1
Discovery of MneHV-7 and MneHV-6 in saliva of pig-tailed macaques by
CODEHOP PCR.
Animal # YGD-SLYP pola,b NPFG-PLEN gBc,b
50 1Cd 60 1Cd 50 1Cd 60 1Cd
M02156 HHV-7 HHV-6 HHV-6 HHV-6
M02383 HHV-7 nd nd nd
L02393 HHV-7 nd nd nd
M03126 HHV-7 nd nd nd
M03182 HHV-7 nd nd nd
nd not detected
a Roseolovirus-speciﬁc CODEHOPs targeting DNA pol gene.
b Detection of novel roseolovirus sequences was based on acrylamide gel
analysis of CODEHOP amplicons.
c Roseolovirus-speciﬁc CODEHOPs targeting glyB gene.
d Annealing temperatures used.
Fig. 1. Schematic representation of targeted CODEHOP motifs, novel macaque roseolovirus amplicons and TaqMan assays relative to the HHV-6B and HHV-7 DNA pol and gB
genes. The genomic structure of the DNA pol and gB genes of HHV-6B (NC_000898) and the HHV-7 (NC_001716) are shown with the highly conserved amino acid motifs
targeted by the CODEHOP PCR primers. CODEHOP amplicons with ﬂanking primers and sequenced gene fragments are shown for A) MneHV-6 and B) MneHV-7.
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standardized plasmids as control templates with inserts contain-
ing the MneHV-6 gB and the MneHV-7 DNA pol regions targeted
by the CODEHOP PCR primers. Several primer combinations and
candidate TaqMan probes were evaluated for efﬁciency and
sensitivity using decreasing concentrations of the recombinant
plasmids. Based on these criteria, a set of primers and probe was
selected for each virus. For both quantitative assays, the standard
curves were linear (r2¼1.0) and their slope coefﬁcients indicated
an ampliﬁcation efﬁciency superior to 90% (data not shown).
Detection of MneHV-6 and MneHV-7 in saliva from pig-tailed
macaques by qPCR
Using the qPCR assays, we determined viral loads for bothMneHV-
6 and MneHV-7 in archived whole saliva samples available from
twelve pig-tailed macaques from the SIV vaccination study, including
the ﬁve animals tested originally by CODEHOP PCR. Of the 12 animals,
ﬁvewere classiﬁed as long term non-progressors, since they were able
to control the SHIV infection with only moderate levels of detectable
SHIV in plasma (SHIV-positive). The remaining seven animals had
developed a sterilizing immunity to the SHIV challenge, with no
detectable SHIV in their blood (SHIV-negative). MneHV-7 was
detected in all 12 saliva samples, while MneHV-6 was detected in
only three SHIV-negative negative animals (Fig. 4). Although the
MneHV-7 viral loads detected in the SHIV-positive animals (median:
1.5105 genome copies/ml) were 4-fold lower than in the SHIV-
negative animals (median: 6105 genome copies/ml), this increase
was not signiﬁcantly different (p¼0.14) These qPCR data conﬁrmed
Fig. 2. Phylogenetic relationship of the novel MneHV-6 and MneHV-7 DNA pol
protein fragments within the Herpesviridae family. The 159aa sequences encoded
by the MneHV-6 and MneHV-7 478bp DNA pol SLYP-YGD CODEHOP amplicon
sequences were compared to analogous protein sequences from other Old World
primate herpesvirinae (see Materials and methods section for accession records)
using maximum likelihood analysis. Members of the Varicellovirus genus and
Simplexvirus genus of the Alphaherpesvirinae subfamily, the Cytomegalovirus
genus (CMV) and Roseolovirus genus (provisional roseolo 1 and roseolo 2 lineages)
of the Betaherpesvirinae subfamily as well as the Lymphocryptovirus genus (LCV)
and Rhadinovirus genus (RV1 and RV2 lineages) of the Gammaherpesvirinae
subfamily are shown. The substitutions per site are indicated. HSV-1 (Herpes
simplex virus 1, HHV-1); HSV-2 (Herpes simplex virus 2, HHV-2); VZV (Varizella-
virus, HHV-3); EBV (Epstein-Barr virus, HHV-4); CMV (cytomegalovirus, HHV-5);
RFHV (retroperitoneal ﬁbromatosis-associated herpesvirus); RRV (Rhesus rhadino-
virus); KSHV (Kaposi's sarcoma-associated herpesvirus, HHV-8 ).
Fig. 3. Phylogenetic relationship of the novel MneHV-6 and MneHV-7 DNA pol
nucleotide sequences within the Roseolovirus genus. The 478bp nucleotide
sequences of the MneHV-6 and MneHV-7 DNA pol SLYP-YGD CODEHOP amplicons
were compared to analogous nucleotide sequences from other Old World primate
roseoloviruses (see Materials and methods section for accession records) using
maximum likelihood analysis. The proposed roseolo 1 and roseolo 2 lineages of the
Betaherpesvirinae subfamily are indicated. The cytomegalovirus hCMV/HHV5 DNA
pol sequence was used as out-group. Branch support values were obtained by using
the approximate likelihood ratio test (aLRT) with Chi2-based parametric statistics.
The substitutions per site are indicated.
Table 2
Sequence comparisons of macaque CODEHOP DNA pol and gB fragments with known Beta-herpesvirus sequences.
Beta-herpesvirinae MneHV-6 MneHV-7
DNA pol (YGD-SLYP; 478bp) %
nucl/aa identity
DNA pol (YGD-DIEC; 1,313bp) %
nucl/aa identity
gB (NPFG-PLEN; 262bp) %
nucl/aa identity
DNA pol (YGD-SLYP; 478bp) %
nucl/aa identity
HHV-6A 75.6/80.5 77.8/84.0 76.7/86.0 60.0/61.6
HHV-6B 76.4/80.5 77.8/84.0 77.9/86.0 59.7/61.6
PanHV6 77.8/80.4 78.8/83.5 76.7/87.2 60.3/61.4
HHV-7 65.3/71.1 67.6/72.7 63.7/65.1 69.3/69.2
MndHVbetaa 61.2/63.5 61.4/63.5 na 60.2/55.3
Betaherpesvirinae used for sequence comparisons including GenBank accession numbers: HHV-6A (Human herpesvirus 6A, strain U1102; NC_001664); HHV-6B (Human
herpesvirus 6B, strain Z29; NC_000898); HHV-7 (Human herpesvirus 7, strain RK; NC_001716); PanHV6 (common chimpanzee herpesvirus 6; AY854171); MndHVbeta
(Mandrill herpesvirus beta; AF282942).
a For MndHVbeta a DNA pol fragment of 478bp (159aa) but no gB sequence was available for comparison with macaque HV sequences.
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our previous CODEHOP PCR results and showed that in contrast to
MneHV-6, and MneHV-7 was highly prevalent in macaque saliva at
high viral loads in this study population.
Longitudinal analysis of MneHV-6 and MneHV-7 oral shedding in
pig-tailed macaques
Viral DNA detected in saliva can have different origins. One
source is infectious virions released from infected oral epithelium
and salivary glands, which is an indication of active viral replica-
tion. Other sources include viral DNA in infected cells sloughed
from the oral epithelium or viral DNA released from lysed/
disrupted infected cells. To assess the level of cell-associated viral
DNA, we fractionated the saliva by centrifugation to obtain a cell
pellet and a cell-free supernatant, which was ﬁltered through a
0.45 μm ﬁlter to remove cellular contamination. The supernatant
contains either DNA from infectious virions that passed through
the ﬁlter or soluble viral DNA released from lysed infected cells.
More recently, oral swabs have been used to quantitate virus in the
oral cavity by gently scraping the accessible epithelial tissue
(Malamud, 2011). The swab captures cells from the outer epithelial
layer and can also absorb a small volume of saliva. Quantitation of
virus in saliva and oral swabs has been used as a measure of viral
shedding and replication. However, the respective ability of the
different collection methods to accurately quantitate and charac-
terize virus in the oral cavity has not been well established.
To study the shedding patterns of MneHV-6 and MneHV-7 in
the oral cavity and to obtain evidence of roseolovirus activation
and replication, archived longitudinal saliva samples from two
SHIV-negative macaques (M02298 and M03240) from the same
SIV vaccine study were assayed for the presence of both viruses.
Both animals had tested positive for MneHV-7 in the initial screen
of a single saliva sample, and one (M03240) was also positive for
MneHV-6 (Fig. 4). Saliva and oral swabs had been collected weekly
from these animals for a total period of 6 weeks. Whole saliva had
been fractionated into a ﬁltered cell-free supernatant and a cell
pellet, and oral swabs had been collected to sample the exposed
epithelium in the oral cavity. DNA was extracted from the different
samples, and MneHV-6 and MneHV-7 viral DNA was quantitated
by speciﬁc TaqMan qPCR assays. MneHV-7 was systematically
detected in both cell-free and cell-associated saliva fractions from
the two macaques over the entire time period (Fig. 5C and D). The
MneHV-7 viral DNA loads in both fractions varied from week to
week for both animals. In contrast, MneHV-6 was detected
sporadically, at only two time points over the same time period
in only one of the two macaques (M03240) (Fig. 5A and B).
MneHV-6 was detected in both the cell-free supernatant and cell
pellet at only one time point and in the cell pellet only at an
additional time point. In this animal, the MneHV-6 loads were
1000 fold lower in the cell-free supernatant and 100 fold
lower in the cell pellet than the corresponding MneHV-7 loads.
For the majority of time points tested, the viral loads for both
MneHV-6 and MneHV-7 were higher in the cell pellet than in the
cell-free supernatant (Fig. 5). Over the entire collection period, the
median level of MneHV-7 genomes/ml of saliva was 13 and 2 fold
higher in the cell pellet compared to the cell-free supernatant in
animals M02298 and M03240, respectively. These viral loads
values were signiﬁcantly different in the case of macaque
M02298 (p¼0.004) but not for M03240 (p¼0.093). At the time
point where MneHV-6 was detected in both fractions in M03240,
the level of MneHV-6 was more than 10 fold higher in the cell
pellet than in the cell-free supernatant. At the other time point in
which M03240 was positive for MneHV-6, no MneHV-6 was
detected in the cell-free supernatant while still detected in the
cell pellet. Currently, we are unable to determine whether the viral
DNA present in the cell-free supernatant is from infectious virus
particles due to the lack of an adequate in vitro model for MneHV-
6 and MneHV-7 propagation. However, our results indicate that
the vast majority of MneHV-7 genomes present in whole saliva of
M02298 and M03240 represents cell associated viral DNA (93%
and 73%, respectively) and not cell-free virus particles.
To further analyze the cell-associated viral DNA, the qPCR data
for MneHV-6 and MneHV-7 were normalized using the OSM
cellular gene qPCR to determine viral genome copies per cell.
The calculated ratio represents an average number of viral genome
copies per cell based on all cells collected in each sample and as
such, underestimates the number of viral genome copies present
only among infected cells in the sample. The viral genome copies
per cell for MneHV-6 in the cell associated fraction of whole saliva
from M0320 from the two time points was at most (on 02-Jul) one
virus copy for every 14 cells (Fig. 5B). In contrast, the median viral
load for MneHV-7 in the cell fraction of whole saliva was 2.6106
and 8.7106 viral genomes/ million cells, in M02298 and M03240,
respectively (Fig. 5D). This average number of viral genomes is
sufﬁcient to have all of the cells present in whole saliva infected
with 2–8 viral genomes per cell, consistent with an overall latent
infection in every cell. If only a fraction of the cells present in
whole saliva were infected then each infected cell would contain a
much higher viral load, suggestive of active viral replication.
To further investigate the origin of the cell-associated viral DNA,
we compared viral loads in cells present in whole saliva with viral
loads in cells sampled from the gum and cheek epithelial surfaces
using the oral swab. MneHV-6 was not detected in the oral swabs
from either macaque at any time point including those times when
virus was detected in the cell-associated fractions of whole saliva
from M03240 (Fig. 6A and B). As seen with whole saliva, MneHV-7
DNA was systematically detected in oral swabs from both animals
over the entire collection period (Fig. 6C and D). The median viral
loads for MneHV-7 in oral swab samples were 3.5105 and 9.3105
viral genomes per million cells in M02298 and M03240, respectively.
Thus, the MneHV-7 load in the cells sampled by the oral swab was
7 to 9 fold lower than the viral load in the cell pellet fromwhole saliva
at the same time point (Fig. 6C and D; p¼0.03 for both M02298 and
M03240). This would indicate that there is either a lower prevalence
of MneHV-7 infected cells in the oral epithelium sampled by the swab
when compared to cells naturally sloughed into saliva, or a lower
level of virus replication in the oral epithelium sampled by the swab.
Surprisingly, there was no correlation between MneHV-7 loads
detected in cells present in whole saliva and cells sampled from the
Fig. 4. Detection and quantiﬁcation of MneHV-6 and MneHV-7 DNA in macaque
saliva. DNA isolated from whole saliva from ﬁve SHIV-positive and six SHIV-negative
pig-tailed macaques that had been challenged with SHIV strain SF162P4 in a previous
SIV vaccine study was tested in duplicate using the MneHV-6 and MneHV-7 qPCR
assays and viral loads were expressed as viral genome copies per ml of saliva.
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Fig. 6. Comparison of cell-associated MneHV-6 and MneHV-7 viral loads in whole saliva and oral swab samples. The viral loads of MneHV-6 (A and B) and MneHV-7 (C and
D) were determined from DNA isolated from the cell fraction of whole saliva (A, C) and from DNA isolated from oral swabs (B, D) collected at the same time point from two
pig-tailed macaques (M03240 and M02298) using the MneHV-6 and MneHV-7 qPCR assays in duplicate. Viral loads are expressed as viral genome copies per cell, as
described in Materials and Methods. MneHV-6 was not detectable in oral swab samples collected from either animal over the entire time period (B).
Fig. 5. Longitudinal analysis of MneHV-6 and MneHV-7 DNA in saliva. Saliva samples were collected weekly for 6 weeks from two SHIV-negative pig-tailed macaques (M03240 and
M02298) from a previous SIV vaccine study. DNAwas isolated from either ﬁltered cell-free saliva supernatants (A, C) or pelleted saliva cells (B, D) from the same saliva samples. Viral
loads for MneHV-6 (A and B) and MneHV-7 (C and D) were determined using the speciﬁc qPCR assays in duplicate and expressed as viral genome copies per ml of saliva.
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epithelium by the swab at identical time points (r2¼0.02, p ¼1.0 and
r2¼0.25, p ¼0.65 for M02298 and M03240, respectively).
Prevalence of MneHV-6 and MneHV-7 in PBMC of
pig-tailed macaques
While we have shown that saliva samples are a good source of
macaque roseolovirus DNA, there is no general archive of macaque
saliva available at the WaNPRC to examine viral prevalence. Human
herpesviruses 6 and 7 were originally isolated from peripheral blood
lymphocytes (Frenkel et al., 1990; Salahuddin et al., 1986), and
peripheral blood mononuclear cells (PBMC) are routinely collected
as part of the WaNPRC colony health monitoring program. There-
fore, we obtained 283 archived PBMC DNA samples from the
WaNPRC to screen for MneHV-6 and MneHV-7 using our speciﬁc
qPCR assays. Samples were considered positive if both qPCR
replicates tested positive. Based on the efﬁciencies for both assays,,
the limit of detection is less than 50 genomes in 300 ng DNA
typically used as template amounts in the PCR reactions. Overall,
MneHV-6 was detected in 29 of the 283 PBMC samples (10%
prevalence) (Table 3). MneHV-7 was detected in 72 of the 283
PBMC samples (25% prevalence). In addition, 12 macaques (4%) had
detectable levels of both viruses in their saliva. To further character-
ize roseolovirus prevalences, animals were grouped based on
gender, age, and origin. Virus prevalence among females was 11%
for MneHV-6 and 24% for MneHV-7, while prevalence among males
was 9% for MneHV-6 and 27% for MneHV-7 (Fig. 7A and B,
respectively), showing no signiﬁcant difference between males and
females.
We also assessed virus prevalence for different age groups. Since
more females than males are used for breeding purposes, female
animals tend to have a larger representation among older animals at
the WaNPRC. In order to compare prevalence between males and
females, we limited the analysis to an age range of 2–10 years where
animals from both genders had a more equal representation.
MneHV-6 prevalence differed remarkably between populations of
females and males. In young male macaques, MneHV-6 DNA was
only detected between the ages of 2 and 4 (Fig. 7A) with a prevalence
of 13% (9/69). Males between the ages of 5 to 10 were negative for
MneHV-6 (0/31). In contrast, MneHV-6 was not detectable in young
females, ages 2–4 (0/57). Females between the ages of 5 and 10 were
positive for MneHV-6, with an overall prevalence of 16% (14/83). The
highest prevalence of MneHV-6 DNA was observed in older females
at 9 years of age (30%). For MneHV-7, virus was detected throughout
the ages 2–7 for both males and females with overall prevalences of
32% for males (N¼90) and 33% for females (N¼113). The highest
prevalence for MneHV-7 was observed in 4 year old males (37%) and
3 year old females (77%) (Fig. 7B).
The WaNPRC manages one of the largest colonies of pig-tailed
macaques in the country. Animals are obtained from several
breeding colonies located in- and outside the United States
(Kanthaswamy et al., 2012). In addition to the Seattle breeding
colony, animals have been obtained from the Medical Lake Primate
Field Station, the Tulane National Primate Research Center, New
Iberia Research Center, USA-Scientiﬁc Resource Center, and from
Indonesia. Additional macaques were also purchased from animal
facilities such as Labs of Virginia Inc., Osage Research Primates, and
the Yerkes National Primate Research Center. Animals originating
from all locations are screened biannually at the WaNPRC as part
of the colony health testing. To determine whether there was a
relationship between virus prevalence and facility of origin,
macaques were stratiﬁed by colony/facility of origin based on
the available information from the animal records (Fig. 8). The
highest MneHV-7 prevalence was observed in pig-tailed macaques
originating from the wild breeding colony in Indonesia (50%) and
the lowest prevalence was observed in animals originating from
the New Iberia Research Center (9%). MneHV-6 was most pre-
valent in animals obtained from the Labs of Virginia (90%) and was
much lower or absent in animals from all other locations. Only one
pig-tailed macaque had been originally purchased from Osage
Research Primates company and tested negative by qPCR for both
MneHV-6 and MneHV-7 (data not shown).
Examination of viral loads in the 283 macaque PBMC samples
revealed an overall median viral load of MneHV-6 (8.0104
genomes/ml blood) that was 7 fold higher than the median viral
load of MneHV-7 (1.0104 genomes/ml blood), which was
signiﬁcantly different (po0.0001). Analysis of PBMC samples
containing both viruses revealed a 4 fold higher median viral load
of MneHV-6 (1.5105 viral genomes/ml blood) in animals with
detectable levels of MneHV-7 compared to animals without
MneHV-7 DNA (4.0104 viral genomes/ml blood), which
was statistically signiﬁcant (p¼0.04) (Fig. 9A). In contrast, the
MneHV-7 median viral load was equivalent in PBMC with or
without detectable MneHV-6 DNA (1.0104 vs 1.0104 viral
Table 3
Prevalence of MneHV-6 and MneHV-7 DNA in macaque PBMC.
MneHV-6 posa MneHV-7 posa
Overall (n¼283) 29 (10.2%) 72 (25.4%)
Females (n¼153) 19 (11.0%) 42 (24.4%)
Males (n¼101) 10 (9.0%) 30 (27.0%)
Virus-speciﬁc qPCR to determine the percent positive (%). Samples were considered
positive ifboth qPCR replicates tested positive.
a Presence of MneHV-6 or MneHV-7 sequence in PBMC was assessed by
Fig. 7. Age-related prevalence of MneHV-6 and MneHV-7 in males and females. The MneHV-6 and MneHV-7 qPCR results of the 283 pig-tailed macaques were sorted by age
(in years) and gender. MneHV-6 (A) and MneHV-7 (B) prevalence in PBMC is reported as percentage of monkeys with a detectable viral load in each age group. The numbers
of samples per age group are indicated.
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genomes/ml blood, respectively) (Fig. 9B). Further analysis
revealed that the increase in MneHV-6 viral loads in MneHV-7
infected PBMC was only observed in the female population (p¼
0.03) (Fig. 9C)
MneHV-6 and MneHV-7 tissue tropism in naturally
infected macaques
HHV-6A has a broad cellular tropism most likely due to the
ubiquitous expression of its essential membrane receptor CD46 on
almost all primate cells. On the other hand, HHV-6B who uses
CD134 as entry receptor is most frequently detected in PBMCs but
surprisingly also in a wide range of tissues (Di Luca et al., 1996).
Similarly, while the known HHV-7 membrane receptor CD4 is only
expressed on a limited set of cell types, HHV-7 has been detected
in many different types of tissues in the human body (Kempf et al.,
1998).
To investigate the tissue tropisms of MneHV-6 and MneHV-7
in naturally infected pig-tailed macaques, the MneHV-6 and
MneHV-7 viral loads were determined for a panel of tissue
samples collected from the initial group of 12 pig-tailed macaques.
The twelve animals were age-matched female pig-tailed maca-
ques. DNA was isolated from formalin-ﬁxed parafﬁn-embedded
tissue sections from biopsies collected from different organs at
necropsy and analyzed by qPCR. Viral loads per cell for each tissue
section were determined using the OSM speciﬁc qPCR.
While only 3 of the 12 animals had tested positive for MneHV-6
DNA in the available saliva samples (Fig. 4), 8 animals had detectable
MneHV-6 DNA in one or more tissues (Table 4), indicating that the
prevalence of MneHV-6 DNA in saliva signiﬁcantly underestimated
the prevalence of MneHV-6 infection in these animals. Four animals
had MneHV-6 DNA in salivary glands (parotid gland) and two of
these (M02156 and M05226) had been positive for MneHV-6 DNA in
saliva. None of the animals had detectable MneHV-6 in gingival and
tonsil samples and only one, M02156, had MneHV-6 DNA in the
cheek sample. In the stomach, tissue biopsies were collected from
Fig. 8. Variation in prevalence of MneHV-6 and MneHV-7 among pig-tailed
macaques from different breeding colonies. Pig-tailed macaques maintained at
the WaNPRC are acquired from different breeding colonies. The prevalence of
MneHV-6 and MneHV-7 was determined in PBMC samples from macaques
grouped by their breeding colony of origin. Prevalence is reported as percentage
of samples with detectable viral loads in PBMCs for each location of origin. The
numbers of samples per colony are indicated. (Medical Lake Primate Field Station:
Medical Lake PFS, Tulane National Primate Research Center: Tulane NPRC, Yerkes
National Primate Research Center: Yerkes NPRC, Washington National Research
Station: WaNPRC, New Iberia Research Center: NIRC, Shin Nippon Biomedical
Laboratories USA-Scientiﬁc Resource Center: SNBL USA SRC).
Fig. 9. Effect of coinfection on MneHV-6 and MneHV-7 viral loads in PBMC. The viral copy number of MneHV-6 and MneHV-7 DNA in PBMC was compared between singly
and co-infected animals. A) MneHV-6 viral loads in MneHV-7 negative and positive macaques; B) MneHV-7 viral loads in MneHV-6 negative and positive macaques; C)
MneHV-6 viral loads in MneHV-7 negative and positive female macaques; D) MneHV-6 viral loads in MneHV-7 negative and positive male macaques. Results are expressed
as viral genome copies per ml of blood. Statistical comparison of groups was performed using an unpaired two-tailed Mann–Whitney t-test and the mean and 95%
conﬁdence interval is indicated.
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three histologically different regions: cardiac, fundic and pyloric. The
cardiac region is located near the esophageal oriﬁce and contains
mainly mucous secreting glands. The fundic region composes the
largest part of the stomach. Gastric glands in the fundic stomach
produce digestive enzymes and hydrochloric acid. The pyloric region
is found proximal to the pyloric sphincter which leads to the
duodenum. Glands in the pyloric epithelium contain specialized
cells secreting either mucus or the peptide hormone gastrin. Seven
of the 8 MneHV-6 positive animals had MneHV-6 DNA in the fundic
stomach tissue. Animals M03182 and M05226 also had MneHV-6
DNA in the cardiac and pyloric stomach tissue, while T05183 was
also positive in the pyloric stomach. M05226, which was positive in
saliva, salivary glands, and all three regions of the stomach, was also
positive in spleen, pancreas and liver. All other animals had no
detectable MneHV-6 DNA in spleen, pancreas, or liver. None of the
animals had detectable MneHV-6 DNA in skin or kidney tissue. The
highest viral loads of MneHV-6 were observed in the fundic region
of the stomach, with up to 6 viral genomes/cell (M03240). This
average ratio of viral genome copies per cell is largely under-
estimated since it is likely that not all the cell types found in the
stomach tissue are infected. Interestingly, none of the SHIV-positive
animals had detectable MneHV-6 in saliva or oral tissues. Further-
more, the only animal (M05226) with widespread MneHV-6 infec-
tion in tissues other than oral and gastric, was SHIV-negative. No
signiﬁcant difference was detected in the MneHV-6 viral loads in the
fundic stomach of the SHIV-positive and SHIV-negative animals.
MneHV-7 DNA was detected in tissues from all 12 macaques of
the original vaccine cohort, which had all tested positive for
MneHV-7 in saliva (Fig. 5.,Table 5). All of these animals had
MneHV-7 DNA in salivary gland tissues. Although MneHV-6 DNA
was only detected in saliva and salivary glands of SHIV-negative
animals, MneHV-7 DNA was detected in saliva and salivary glands
of both SHIV-positive and SHIV-negative animals. However, the
highest MneHV-7 viral loads in saliva and salivary gland were
detected in a SHIV-negative animal (M03240) and the median
MneHV-7 viral loads in the saliva and salivary gland were 4 and 27
fold higher in the SHIV-negative animals compared to the SHIV-
positive animals, respectively. Since two of the seven SHIV-
negative animals had low levels of MneHV-7, these differences
were not signiﬁcant. Six animals had MneHV-7 in other oral
tissues, including cheek, gingiva and/or tonsils. All animals except
for M03126 had MneHV-7 in the stomach with 6/12 positive in the
fundic region, 7/12 positive in the cardiac region and 9/12 positive
in the pyloric region. Two of the 12 animals were positive for
MneHV-7 in spleen, while none were positive in skin, pancreas,
liver or kidney.
The highest MneHV-7 viral loads were detected in salivary
glands attaining an average ratio of 24 viral genomes per cell
(M03240). This viral load strongly suggests that active viral
replication was ongoing in salivary gland tissues. High viral loads
were also detected in the stomach, with loads reaching an average
of 8 viral genomes per cell in the pyloric stomach sample (L02393).
Table 4
MneHV-6 tissue distribution in naturally infected pig-tailed macaques.
Animal SHIVa Salivab Skin Cheek Gingiva Tonsil Parotid gland Fundic stomach Cardiac stomach Pyloric stomach Spleen Pancreas Liver Kidney
M03182 þ – – – – – – 2n103 7n103 4.9n103 – – – -
K03258 þ – – – – – – 5.4n104 – – – – – –
M04082 þ – – – – – – 3.1n106 – – – – – –
T05183  – – – – – 5.7n104 9.5n102 – 9n103 – – – –
M02156  2.1n104 – 1n104 – – 8.1n101 – – – – – – –
L02393  – – – – – 1.1n106 2.5n104 – – – – – –
M03240  2.0n105 – – – – – 6.2n106 – – – – – –
M05226  3.6n104 – – – – 3.7n104 1.9n104 7.8n104 1n105 1n104 2.7n104 1.9n104 –
DNAwas isolated from formalin-ﬁxed parafﬁn-embedded tissue sections obtained at necropsy from ﬁve SHIV-positive long-term non-progresssors and seven SHIV-negative
macaques that had been differentially vaccinated and challenged with SHIV strain SF162 P4 in a previous SIV vaccine study. Viral loads were determined using the MneHV-6
and cellular OSM qPCR assays in duplicate and are reported as average MneHV-6 genome copies per million cells, as described in Materials and Methods. Two of the SHIV-
positive and two of the SHIV-negative animals had undetectable levels of MneHV-6 in all samples tested (not shown).
a SHIV status of the animals was determined by weekly testing of SHIV viral loads in plasma by SHIV qPCR
b MneHV-6 genome copies / ml whole saliva, which had been collected at various time points at or before necropsy.
Table 5
MneHV-7 tissue distribution in naturally infected pig-tailed macaques.
Animal SHIVa Salivab Skin Cheek Gingiva Tonsil Parotid gland Fundic stomach Cardiac stomach Pyloric stomach Spleen Pancreas Liver Kidney
M03182 þ 1.5n105 – 9.6n102 – 2n102 4.6n104 – 5.7n102 8.9n103 4n104 – – –
M03126 þ 7.7n104 – – – – 1.6n105 – – – – – – –
A03188 þ 2.1n105 – – – – 4.2n104 – 8.7n102 – – – – –
K03258 þ 8.2n104 – – – 7n101 5.1n104 5.8n103 – – – – – –
M04082 þ 2.4n105 – 6n102 – 2n103 1.8n105 1.9n106 – 3.1n103 – – – –
T05183  2.7n106 – – 1.9n103 – 3.2n106 2.8n104 5.2n104 3.3n106 9.9n102 – – –
M02156  1.3n105 – – – – 1.4n106 – 2.1n103 1.4n105 – – – –
L02393  1.1n106 – – – – 1.4n106 8.2n103 1.3n104 8.3n106 – – – –
M03240  2.0n108 – 1.6n103 – – 2.4n107 2n105 - 2.5n105 – – – –
M02298  5.9n105 – – – – 2.1n107 – 9.3n103 1.9n103 – – – –
M02383  5.5n104 – 4.7n102 – – 8n103 – – 8.3n103 – – – –
M05226  5.7n105 – – – – 7n103 4.7n103 2.1n104 2.3n104 – – – –
DNA was isolated from formalin-ﬁxed parafﬁn-embedded tissue sections obtained at necropsy from ﬁve SHIV-positive long-term non-progressors and seven SHIV-negative
macaques that had been differentially vaccinated and challenged with SHIV strain SF162 P4 in a previous SIV vaccine study. Viral loads were determined using the MneHV-7
and cellular OSM qPCR assays in duplicate and are reported as the average MneHV-7 genome copies per million cells, as described in Materials and Methods.
a SHIV status of the animals was determined by weekly testing of SHIV viral loads in plasma by SIV qPCR
b MneHV-7 genome copies / ml whole saliva, which had been collected at various time points at or before necropsy
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This average ratio of viral genome per cell is unlikely to represent a
widespread latent infection but rather a lytic replication in a
limited number of cells present in these tissue samples.
The spread of MneHV-7 infection in spleen, tonsil, cheek and
gingival epithelium was variable in the 12 animals with low viral
loads. While there was no statistically signiﬁcant difference
between MneHV-7 levels in SHIV positive and SHIV negative
animals for most tissues (salivary glands: p¼0.25; fundic stomach:
p¼0.49; and cardiac stomach: p¼0.33), the MneHV7 viral loads in
the pyloric stomach were signiﬁcantly higher in SIV-negative
animals compared to SIV-infected animals (P¼0.016).
We also examined the relationship between the viral load of
MneHV-7 in whole saliva and in orogastric tissues (salivary glands
and pyloric stomach) for all twelve macaques. Interestingly, a
strong correlation was detected not only between MneHV-7 loads
in whole saliva and salivary glands (r2¼0.61, p¼0.039) but also
between whole saliva and the pyloric stomach (r2¼0.62, p¼0.034)
(Fig. 10). This data suggests that MneHV-7 infection status in
different organs within the orogastric system is reﬂected in the
viral loads detected in whole saliva.
Discussion
This study provides the ﬁrst identiﬁcation and characterization
of two new roseolovirus homologs of HHV-6 and HHV-7 naturally
infecting pig-tailed macaques (Macaca nemestrina). Pig-tailed
macaques are one of the major macaque species maintained at
the WaNPRC, and are commonly used for biomedical research
since they develop disease pathologies similar to those seen in
humans. Using a CODEHOP PCR primer approach, we identiﬁed
the provisionally named MneHV-6 and MneHV-7 viruses based on
the ampliﬁcation of a 1575bp and a 478bp DNA segment with
homology to the HHV-6 and HHV-7 genome sequences, respec-
tively. It was of interest that the same CODEHOP PCR primers
targeting the conserved roseolovirus DNApol gene ampliﬁed the
MneHV-6 sequence at one annealing temperature (60 1C) and the
MneHV-7 sequence at a lower annealing temperature (50 1C),
highlighting the importance of a comprehensive molecular strat-
egy for the discovery of novel viruses even in closely related
species. Complete sequencing of the MneHV-6 and MneHV-7
genomes will be needed to fully determine the structural and
functional similarities between these viruses and their counter-
parts in humans.
Phylogenetic analysis of the DNA pol gene fragments conﬁrmed
that MneHV-6 and MneHV-7 belong to separate Roseolovirus
lineages. The MneHV-6 sequence clustered together with sequences
of the two HHV6 viruses (6A) and (6B) and PanHV6, a chimpanzee
virus closely related to HHV6, within a lineage we have provision-
ally termed roseolo 1. MneHV-7 clustered together with HHV7 and
MndHVbeta, a herpesvirus from mandrills, an Old World monkey
related to baboons, within a tentatively named roseolo 2 lineage.
While only one chimpanzee roseolovirus PanHV6 and one mandrill
roseolovirus, MndHVbeta have been identiﬁed so far, our discovery
of MneHV6 and MneHV7 in macaques clearly demonstrates that the
two Roseolovirus lineages existed before the divergence of monkeys
and hominoids, some 30 million years ago. We observed signiﬁ-
cantly longer branch lengths in the DNA PhyML analysis of the
roseolo 2 lineage DNA pol gene fragments (Fig. 3), suggesting a
higher rate of evolutionary divergence than seen in the roseolo
1 lineage. Analysis of additional gene fragments will be necessary to
conﬁrm this evolutionary difference. Within the roseolo 1 lineage,
the HHV-6A and HHV-6B sequences clustered closely together in
our analysis (Fig. 3), distinct from the PanHV6 and MneHV-6,
suggesting that the divergence of the two HHV-6 species occurred
after the divergence of chimpanzees from humans. Thus, we
would not expect to see separate macaque homologs of HHV-6A
and HHV-6B.
Using the available sequence information, we designed speciﬁc
PCR assays to detect and quantitate the levels of MneHV-6 and
MneHV-7 in tissue to determine virus prevalence, oral shedding
patterns, and tissue tropism. Initially, we examined available saliva
samples from a cohort of twelve pig-tailed macaques that were
part of an experimental SIV vaccination study (Polacino et al.,
2008). While these macaques had undergone different vaccination
protocols, they had all been challenged with SHIV (Vlasak and
Ruprecht, 2006). Four to six years post challenge the macaques
were still healthy, with ﬁve showing evidence for a low level
ongoing SHIV infection, while the remaining seven animals
showed no evidence of SHIV in plasma samples. We fractionated
the saliva to determine the respective contribution of cell-free and
cell-associated virus to the viral DNA shed into saliva. While
MneHV-6 and MneHV-7 DNA was detected in both cell free
supernatant and the cell pellet of whole saliva, the ratio of cell-
free to cell-associated viral DNA was variable. In most instances,
the cell-associated DNA constituted the vast majority of the viral
DNA in whole saliva. Thus, the quantitation of viral DNA in whole
saliva does not appear to be a valid measure of the level of cell-free
infectious virions present in saliva.
Oral swabs have been used to monitor different herpesviruses
in the oral cavity and increases in the level of viral DNA in the oral
material collected by the swab has been attributed to active virus
replication. Such data have been used to monitor disease progres-
sion and response to therapy in herpesvirus-associated diseases,
such as Kaposi's sarcoma (Casper et al., 2008). The oral swab
collection procedure used in our study was modeled after similar
procedures used in human studies, and samples primarily surface
cells from cheek and gingival epithelia with minimal absorption of
liquid saliva. We compared the level of MneHV-6 and MneHV-7
DNA detected by oral swabs with the level of viral DNA in whole
saliva, assaying both the cell-free supernatant, which is predicted
to contain free infectious virions and the cell pellet containing cell-
associated latent or replicating viral genomes. The origin of cells
naturally sloughed into saliva is not clear, but previous studies
have indicated that these cells may be a mixture of oral epithelial
cells and lymphocytes (Thiede et al., 2000). We saw no correlation
between viral loads in the cell-free supernatant and cells in whole
saliva or cells collected by oral swab. The lack of correlation
between the infection status of the swab-sampled epithelial cell
populations and the saliva-associated cell populations suggests
that these two populations are not the same and have different
epithelial origins in the oral cavity with different susceptibilities to
Fig. 10. Correlation between MneHV-7 loads in saliva and orogastric tissues. The
MneHV-7 viral loads in whole saliva (genome copies/ml saliva) were compared to
the viral loads in the salivary gland and pyloric stomach tissue (genome copies/
million cells). Tissues were obtained at necropsy, while saliva samples were taken
at various earlier time points. Statistical signiﬁcance of the correlations was
assessed by two-tailed Spearman nonparametric correlation with 95% conﬁdence
intervals (salivary glands: r2¼0.61, p¼0.039; pyloric stomach r2¼0.62, p¼0.034).
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roseolovirus infection and/or activation. A possible tissue site of
more highly infected cells is the tongue epithelium which has
been reported to host different herpesviruses including HHV-6
(Chen and Hudnall, 2006). Further studies are needed to deter-
mine the nature and origin of the MneHV-6 and MneHV-7 infected
cells in whole saliva. While our studies speciﬁcally targeted the
oral presence of the macaque homologs of HHV-6 and HHV-7, our
results suggest caution in interpreting the level of herpesvirus
DNA obtained by oral swab collection as indicative of virus
replication in saliva. Similar to what has been reported for HHV-7
(Fujiwara et al., 2000), our data suggests that MneHV-7 is more
easily detected in saliva samples than in oral swabs. While we
cannot rule out special circumstances for infection and/or activa-
tion of virus in our cohort of 12 vaccinated macaques, it is clear
that viral infection and/or activation was not equivalent for the
two viruses, as only three out of twelve animals had detectable
MneHV-6 in whole saliva while MneHV-7 levels were consistently
high in all animals. We also observed that MneHV-7 was more
prevalent than MneHV-6 in a survey of PBMC from 283 macaques.
Overall, 25% of the animals had detectable MneHV-7 DNA in
PBMC, 10% had detectable MneHV-6 DNA, and 4% of the animals
were co-infected with both viruses. The higher prevalence of viral
DNA in tissue biopsies suggests that the actual prevalence of
MneHV-6 and MneHV-7 infections at the WaNPRC may be con-
siderably higher. Previous studies have shown that roseolovirus
prevalence varies by geographic location (Braun et al., 1997;
Cleghorn et al., 1995; Krueger et al., 1998). Our data showed that
overall prevalences of MneHV-6 and MneHV-7 varied between
macaque populations from different breeding colonies. Examina-
tion of the animal records indicated that the PBMC samples from
the colony health screen had been obtained from animals originat-
ing from the WaNPRC and a variety of other primate centers or
facilities. While the majority of macaques from geographically
dispersed facilities showed a much higher prevalence of MneHV-7
DNA in PBMC than MneHV-6, the percentage of infected animals
varied remarkably. Similar to their human homologs, the macaque
roseoloviruses are likely to be transmitted by exposure to saliva,
suggesting that virus prevalence is affected by differences under
housing conditions and frequency of social contact with other
macaques in each colony.
Disease manifestations associated with viral infections often
vary depending on the patient's sex and age (Eshima et al., 2012).
A previous study has reported that HHV-6 acquisition is more
frequent in girls than boys (Zerr et al., 2005). In our studies, the
overall prevalence of MneHV-6 and MneHV-7 DNA in PBMC was
similar for male and female macaques and mirrored the preva-
lence for the combined population. MneHV-7 was detected in both
males and females, with a higher prevalence in the younger
animals that tended to decrease with age. In contrast, we observed
a strong gender bias for MneHV-6 when samples were compared
by age groups. MneHV6 was only detected in young males and
older females. Multiple studies have reported a possible associa-
tion between HHV-6 and disease exacerbation among patients
with multiple sclerosis (MS) (Alvarez-Lafuente et al., 2004;
Behzad-Behbahani et al., 2011). MS occurs later in life and is known
to be more common among females than males (Milo and Kahana,
2010). In this context, our observation of a higher prevalence of
MneHV-6 infections in PBMC of older female pig-tailed macaques is
of interest, as it suggests activation of the HHV-6 homolog in this
population.
During the broad screen of macaque PBMC samples, we detected
signiﬁcantly higher viral loads of MneHV-6 DNA compared to
MneHV-7. This was mostly due to the fact that MneHV-6 viral loads
were much higher in animals co-infected with both MneHV-6 and
MneHV-7 than in animals in which only MneHV-6 was detected. In
contrast, the viral load of MneHV-7 was not increased in animals
co-infected with MneHV-6. This suggests that in vivo gene expression
and/or replication of MneHV-7 can signiﬁcantly increase MneHV-6
viral loads in the peripheral blood and conﬁrms previous in vitro
observations for HHV-6B and HHV-7 (Katsafanas et al., 1996; Tanaka-
Taya et al., 2000). We also found that this increase was most
prominent among females. A possible factor is that the co-infected
animals were older among the females than the males. Currently, we
are investigation whether there are lymphocyte subpopulations that
are co-infected with both MneHV-6 and MneHV-7 to identify
mechanisms by which MneHV-7 might trigger MneHV-6 reactivation.
As is the case for other herpesviruses, primary infection with
either HHV-6 A/B or HHV-7 is followed by a lifelong chronic
infection (Jarrett et al., 1990; Kidd et al., 1996). Virus persists
latently in reservoirs of infection with occasional episodes of viral
reactivation. HHV-6 and HHV-7 are frequently detected in oro-
pharyngeal, gastrointestinal and lymphoid tissues (Chen and
Hudnall, 2006). Our qPCR data indicated that MneHV-7 was
present in tissue samples from all 12 pig-tailed macaques studied,
while MneHV-6 was only detected in 8 of the 12 monkeys. Our
mapping of anatomical sites of infections is in agreement with
previous studies performed in humans (Chen and Hudnall, 2006;
Kempf et al., 1998), although HHV-6 and HHV-7 were detected in a
broader range of tissues. This discrepancy might be due to the fact
that screening for HHV-6 and HHV-7 mostly relied on nested PCR
assays that have a higher sensitivity than our assays allowing for
detection of low, often latent, tissue infection.
The viral loads detected in tissues by our qPCR assays were
often lower for MneHV-6 compared to MneHV-7. Both viruses
were frequently detected in different parts of the stomach and in
salivary glands. The highest measured viral loads were detected in
tissue samples from these two anatomical sites indicating that
viral reactivation and active replication could take place in these
organs. Occasionally, MneHV-6 and MneHV-7 were also detected
in lymphoid organs like tonsil or spleen at viral loads compatible
with a latent stage of infection as described for their human
homologs (Kempf et al., 2000; Roush et al., 2001).
Absence or low levels of MneHV-7 detected by the qPCR assay
in oral epithelia from the cheek and gingiva mirrored the results
from the oral swab samples and suggested the presence of low
levels of latent, non-replicating MneHV-7 genomes. Conversely,
the MneHV-7 loads present in cells in whole saliva were much
higher, indicative of virus activation and genome replication. A
strong correlation was detected between the MneHV-7 viral loads
in whole saliva and viral loads in both the stomach and salivary
glands, suggesting concomitant virus activation in different
regions of the orogastric epithelium. Apparently, these desqua-
mated oral epithelial cells are different from the cells sampled
using the oral swab technique. It is tempting to speculate that
infected cells present in saliva, when swallowed, play an important
role in the observed MneHV-6 and MneHV-7 infections in the
different regions of the stomach.
HHV-6A/B and HHV-7 have been increasingly recognized as
important pathogens associated with severe complications in
transplant patients (Razonable et al., 2009). HHV-6 in particular
is often associated with acute liver failure and pancreatitis
(Cacheux et al., 2005; Randhawa et al., 1997). Although we
detected MneHV-6 in a smaller number of tissue samples than
MneHV-7, MneHV-6 was still uniquely detected in pancreas and
liver tissue samples from a naturally infected pig-tailed macaque.
An inherent problem facing roseolovirus studies in humans is the
difﬁculty of obtaining biopsy specimens from asymptomatic
healthy persons for obvious ethical reasons. Hence, the availability
of an animal model for natural infection with roseoloviruses is of
particular interest since it would allow for a better understanding
of the life cycles of these viruses in different organs including in
the context of immunosuppression. Efforts to further characterize
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tissue location and cellular tropism using histological staining are
currently underway.
Although our study was not designed to evaluate the impact of
SHIV exposure on MneHV-6 and MneHV-7 infections, we observed
that ongoing SHIV infection (SHIV-positive) in long term non
progressing animals was associated with decreased levels of
MneHV-6 and MneHV-7 in saliva and gastrointestinal tissues
when compared to SHIV-negative macaques. Furthermore, only
SHIV-negative macaques had detectable MneHV-6 in saliva, even
though several SHIV-positive animals were infected with MneHV-
6. Since HIV infection has been associated with salivary gland
hypertrophy and marked secretory hypofunction (Fox, 1991) it is
possible that the adverse effect of SHIV infection on salivary glands
functions resulted in a decrease of roseolovirus DNA loads released
into saliva. Further studies will be needed to evaluate more
comprehensively the interactions between SIV, MneHV-6 and
MneHV-7 in co-infected macaques.
The existence of roseolovirus homologs in non-human pri-
mates had been suggested based on serological data (Higashi et al.,
1989). Attempts to ﬁnd HHV-6-like sequences in pig-tailed maca-
ques by HHV-6-speciﬁc PCR failed, which led to the assumption
that these animals are not commonly infected by a virus related to
HHV-6 (Lusso et al., 1994a). Our studies clearly show that pig-
tailed macaques are naturally infected with two distinct roseolo-
viruses closely related to HHV-6 and HHV-7, suggesting that
MneHV-6 and MneHV-7 infections in macaques would be an
important non-human primate model of roseolovirus infections
and pathology. Taken together, our discovery and initial analysis of
two novel roseolovirus homologs in macaques offers a unique
opportunity to develop relevant animal models using viruses
native to the host to answer various unresolved questions sur-
rounding their biology and respective roles as etiological agents in
diseases.
Materials and methods
Saliva and tissue samples
Peripheral blood mononuclear cells (PBMC) were isolated from
whole blood collected from 283 pig-tailed macaques during the
biannual colony health screening at the Washington National
Primate Research Center (WaNPRC). Saliva samples were from
stored aliquots from pig-tailed macaques that had been part of a
previous simian immunodeﬁciency (SIV) vaccine study. All ani-
mals in this study were housed and cared for according to the
Guide for the Care and Use of Laboratory Animals at the Washington
National Primate Research Center (WaNPRC), an Association for
Assessment and Accreditation of Laboratory Animal Care Interna-
tional accredited institution. The experimental procedures were
approved by the Institutional Animal Care and Use Committee
(2370-20) at the University of Washington and conducted in
compliance with the Public Health Services Policy on Humane
Care and Use of Laboratory Animals (http://grants.nih.gov/grants/
olaw/references/PHSPolicyLabAnimals.pdf). The animals were kept
under deep sedation during the saliva collection procedures with
ketamine HCl at the dose of 10–15 mg/kg intramuscularly to
alleviate any pain and discomfort. The animals were monitored
by the Animal Technician or Veterinary Technologist while under
sedation. Tissues collected at necropsy were either frozen or ﬁxed
in 10% neutral buffered formalin and embedded in parafﬁn.
Preparation of DNA from saliva and tissues
To separate whole saliva into a cell-free fraction and cell pellet,
600 μl of whole saliva was centrifuged (5 min, 2,500 rpm) to pellet
any cells. Supernatants were collected and ﬁltered using a 0.45 μm
acrodisk ﬁlter (PALL, Port Washington, NY). Oral swab samples
were obtained using sterile polyester tipped swabs (Puritan,
Guilford, ME) by passing the swab over the inside of both cheeks,
along the upper and lower gum-lines, around the hard palate and
across the soft palate. Formalin-ﬁxed parafﬁn-embedded tissue
was treated with xylene to remove parafﬁn, followed by extensive
ethanol washes prior to DNA isolation. DNA was extracted from
whole saliva, saliva supernatant and cell pellet, oral swab and
tissue samples using proteinase K at 56 1C and the QIAamp DNA
Mini Kit (Qiagen, Valencia, CA), following the manufacturer's
protocols.
Consensus degenerate hybrid oligonucleotide primer
(CODEHOP) design
Several CODEHOP primer pairs targeting the highly conserved
DNA polymerase (DNA pol) and glycoprotein B (gB) genes were
designed as previously described (Rose, 2005) from an alignment of
available human and non-human primate beta-herpesvirus protein
sequences (see below) as well as one bat beta-herpesvirus sequence
(Wibbelt et al., 2007). The iCODEHOP software (Boyce et al., 2009)
was used to determine short conserved amino acid motifs in the
DNA pol and gB genes from which the degenerate core for each
CODEHOP primer was designed. The consensus portion for each
CODEHOP primer was designed from the consensus of all aligned
beta herpesvirus nucleotide sequences ﬂanking the degenerate
core. Additional modiﬁed CODEHOPs were designed by modifying
core and/or consensus sequences to bias the primers to resemble
more closely the roseolovirus nucleotide sequences in the align-
ment. Optimal primer combinations were chosen after comprehen-
sive testing of multiple CODEHOP primer combinations. PCR assays
were performed across a temperature gradient from 50 1C to 70oC
using as template the human T-cell line HBS-2 infected with the
HHV-6B strain Z29. The CODEHOP primer pairs with the best
sensitivity for HHV-6B detection were used to screen mac-
aque DNA samples. CODEHOP primer pairs targeting roseolovirus
DNA pol sequences are shown with the predicted amplicon
sizes: SLYP-F (50–GCCTACTGTGGTGTTTGATTTTCAGAGYYTSTAYCC-
30) x YGD-R (50- CTGACAGACATAAAGATGCTATCCGTATCACCATA-
30), 549bp; DIEC-F (50- GGCCTTTATATGGATGCTGGTCCTTCGAYATW-
GARTG -30) x CNS-R (50- GCCGCTCCCGTCACACCGTACACIGARTTRCA
-30), 1,218bp. The CODEHOP primer pair targeting roseolovirus gB
sequencsis shown with the predicted amplicon size: PLEN-F
(50- CTAAAGATCGATCCTCTAGAAAATGCNGATTTTA-30) x NPFG-R
(50- ATCAACATGAGACCACCCCCRAATGGATTT-30), 326bp.
Protocol for CODEHOP PCR
PCR and thermal denaturation were conducted on a Roche
LightCycler 480 II, with accompanying software release 1.5.0. The
ampliﬁcation reaction mix included 1x PCR buffer (Life Technol-
ogies, Grand Island, NY), 0.4 mM each dNTP (Bioline, Taunton,
MA), 2 mM MgCl2, 0.5 U/reaction HS Taq polymerase (Kapa
Biosystems, Wilmington, MA), 0.4 mM of each the forward and
the reverse CODEHOP primer pools, and 2 mL of template DNA. For
the initial CODEHOP primer optimization, quantitative PCR was
performed by adding 0.4 SYBRgreen (Life Technologies, Grand
Island, NY) to the reaction mix. The ampliﬁcation protocol for
CODEHOP PCR was as follows: incubation of ampliﬁcation reaction
mix (25 μl/assay) at 94 1C for 2.5 min, followed by 45 cycles at
94 1C for 15 s, annealing at 50 1C or 60 1C for 30 s (or gradient from
50 1C to 65 1C for 30 s for gB screening), and 72 1C for 15 s, then
cooled for 1 min at 37 1C, all at maximum ramp speed of 4.4 1C/s.
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Sequence analysis of CODEHOP amplicons by Sanger sequencing
PCR amplicons obtained from the CODEHOP PCR reactions
were analyzed by gel electrophoresis and bands of the appropriate
size were excised and prepared for sequencing using the BigDyes
Terminator v3.1 Cycle Sequencing Kit following the manufacturer's
instructions (Life technologies, Grand Island, NY).
Comparative and phylogenetic analysis
Sequence data was evaluated using the Geneious software
package (v6.1.6; Biomatters Ltd., Auckland, NZ). Amplicon
sequences were aligned with known beta-herpesvirus sequences
using Muscle (for amino acid sequences) or the Geneious align-
ment algorithm (for nucleotide sequences) and sequence identity
was determined. Phylogenetic analysis was performed using the
Maximum Likelihood method (PhyML) with the JC69 substitution
model (Guindon and Gascuel, 2003) from Muscle or Geneious
alignments of herpesvirus nucleotide or amino acid sequences.
The number of substitution rate categories was set at 4, and the
best of both NNI and SPR topology searches was combined into the
ﬁnal tree. The percent likelihood of branching within the phylo-
genetic tree (Fig. 3) was obtained by using the approximate
likelihood ratio test returning Chi2-based parametric branch sup-
ports (Anisimova and Gascuel, 2006). The ﬁnal phylogenetic trees
were visualized using Geneious or FigTree v1.3.1 [http://tree.bio.
ed.ac.uk/software/ﬁgtree/].
GenBank references
The following herpesvirus DNA pol protein sequences were used to
construct the phylogenetic tree for Fig. 2: Alphaherpesvirinae:
a) Varicellovirus: HHV3 / VZV (NP_040151), CeHV9. Simian VZV
(NP_077443), b) Simplexvirus: McHV1 / macaque Herpes B
(NP_851890), HSV1 (NP_044632), HSV2 (NP_044500), PanHValpha1
(AFV26919); Betaherpesvirinae: a) Cytomegalovirus: McHV3 /
MmuCMV (O71121), MfaCMV (AAW55912), MndCMV (AAM89-
282), HHV5 / hCMV (YP_081513), PnHV2 / panCMV (NP_612698);
b) Roseolovirus: (roseolo1 lineage): PanHV6 (AAW55996), HHV6A
(P28857), HHV6B (Q9QJ32); (roseolo2 lineage): MndHVβ (AAG390-
65), HH7 (AAC40752); Gammaherpesvirinae: a) Lymphocryptovirus:
PnHV1 / PanLCV (ADY05316), HHV4 / EBV (P03198), MndLCV1
(ADY05317), MfaLCV1 (ADY05313), McHV4 / MmuLCV1 (YP_06-
8007); b) Rhadinovirus: (RV1 lineage): RFHVMn (AAF81662), MfaRV1
(AAN35122), McHV5 / RFHVMm (AAC57976), MndRHV1 (AAG39066),
HHV8 / KSHV (AAC57974),PanRV1 (AAN35124); (RV2 lineage):
PanRV2 (ABU52897), MndRHV2 (AAG39063), MfaRV2 (ABU52895),
RRV (NP_570750), MneRV2 (AF204167). Nucleotide accession num-
bers used for sequence comparisons and phylogenetic analysis in Fig. 3
are as follows: HHV6A (NC_001664), HHV6B (NC_000898), PanHV6
(AY854171), HHV7 (NC_001716), MndHVbeta (AF282942).
MneHV-6 and MneHV-7 speciﬁc TaqMan qPCR assays
PCR primers and TaqMan probes for quantitative real-time PCR
assays (qPCR) speciﬁcally targeting either the MneHV6 or the
MneHV7 virus were designed based on the sequences of the partial
MneHV6 gB and MneHV7 DNA pol gene segments ampliﬁed from
the CODEHOP assays, using the modiﬁed Primer3 software available
on the IDT website (Integrated DNA Technologies, Coralville, IA).
Probe and primer sequences were as follows: MneHV7 DNA pol
probe (50-[6FAM]ACTGGTGCAACACATAGCTTATTACCGT[BHQ1] -30);
forward primer: MneHV7-pol-F (50–GTGCA;AAGACCCTACGTTAAT-
TATG-30); reverse primer: MneHV7-pol-R (50–CTTGTTACCG-
AAGCAGCAATAG-30); MneHV6 gB probe (50- [6FAM]CGCCGT-
CGTATGTCAATGGCC[BHQ1] -30); forward primer: MneHV6-gB-F
(50–TCCCCGGATGAATTGAGTAG-30); reverse primer: MneHV6-gB-R
(50–TAGGTACAGGGTTGGGATCG-30). PCR and thermal denaturation
were conducted on a Roche LightCycler 480 II, as described above,
using 1 PCR buffer (Life Technologies, Grand Island, NY, USA),
0.2 mM each dNTP (Bioline, Taunton, MA), 3 mM MgCl2, 0.5 U/
reaction HS Taq polymerase (Kapa Biosystems, Wilmington, MA),
1 mM of each the forward and the reverse CODEHOP primer, 0.1 mM
probe and 1 mL of template DNA. The ampliﬁcation protocol for
qPCR was as follows: incubation of ampliﬁcation reaction mix
(25 μl/assay) at 94 1C for 2.5 min, followed by 45 cycles of 94 1C
for 30 s, 60 1C for 30 s and 72 1C for 30 s (single acquisition), then
cooled for 1 min at 37 1C, all at maximum ramp speed of 4.4 1C/s. All
samples were run in duplicate reactions. Viral load was determined
by comparing the Ct values obtained with the MneHV-6 and
MneHV-7 qPCR assays with the Ct value obtained from a single
copy cellular gene, oncostatin M, as described previously (Bruce et
al., 2005). Standard deviation was calculated based on the delta
delta CT (Livak and Schmittgen, 2001).
Standardized plasmids
The CODEHOP SLYP-YGD (MneHV-7) and PLEN-NPFG (MneHV-6)
amplicons were excised from 1% agarose gels, ligated into the pJET
vector and transformed into competent DH5α cells. Selected colonies
were sequenced to conﬁrm the DNA insert and plasmid DNA was
prepared as standardized templates for the MneHV-6 and MneHV-7
qPCR assays.
Statistics
Statistics was performed using GraphPad Prism version 6.01 for
Windows, (GraphPad Software, La Jolla California USA. The statistical
signiﬁcance of differences in viral loads for groups of samples was
calculated using the unpaired two-tailed Mann–Whitney t-test or the
Wilcoxon matched-pairs signed rank test with 95% conﬁdence inter-
vals. To compare viral loads between saliva and salivary gland or
pyloric stomach samples (Fig. 10), respectively, two-tailed Spearman
nonparametric correlation coefﬁcients (r2) and corresponding P-values
were calculated using 95% conﬁdence intervals.
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